Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Assay for prostate specific antigen (PSA): problems and possible solutions

J T Wu1

  • 1Department of Pathology, University of Utah School of Medicine, Salt Lake City.

Journal of Clinical Laboratory Analysis
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 antibodies for specificity and function in clinical infection and asymptomatic cases: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Nowcasting COVID-19 transmission dynamics, severity, and effectiveness of control measures: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2025
Same author

Risk prediction analytics for the Hong Kong Colorectal Cancer Screening Programme: abridged secondary publication.

Hong Kong medical journal = Xianggang yi xue za zhi·2023
Same author

[The impact of obstructive sleep apnea hypopnea syndrome on the perioperative and long-term outcome in patients with Stanford type A aortic dissection].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2021
Same author

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Clinical assessment of COVID-19 outbreak among migrant workers residing in a large dormitory in Singapore.

The Journal of hospital infection·2020
Same journal

Organ-Specific Human Microbiomes and Dysbiosis: Mechanistic Links to Disease and Emerging Therapeutic Strategies.

Journal of clinical laboratory analysis·2026
Same journal

Measurement of Plasma Free Hemoglobin Using the Hemolysis Index of the Mindray BS-800.

Journal of clinical laboratory analysis·2026
Same journal

IGFBP3 As a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma: A Multi-Cohort Analysis.

Journal of clinical laboratory analysis·2026
Same journal

Optimization of Reflex Testing Rules on the Sysmex XN-9100 Automated Hematology Line Improves Efficiency and Reduces Repeat Testing in Different Work Areas.

Journal of clinical laboratory analysis·2026
Same journal

sFlt-1/PlGF Ratio in the Diagnosis of Preeclampsia on the MAGLUMI X3 Analyzer.

Journal of clinical laboratory analysis·2026
Same journal

Application of Cell-Free DNA Barcode-Enabled Single-Molecule Test for Non-Invasive Prenatal Testing of α-Thalassemia and β-Thalassemia.

Journal of clinical laboratory analysis·2026
See all related articles

Current prostate-specific antigen (PSA) tests struggle with accuracy. Measuring the PSA-alpha 1-antichymotrypsin (PSA-ACT) complex may improve prostate cancer diagnosis and differentiate it from benign prostatic hyperplasia (BPH).

Area of Science:

  • Biochemistry
  • Oncology
  • Clinical Diagnostics

Background:

  • Prostate-specific antigen (PSA) is crucial for prostate cancer screening and recurrence detection.
  • Current PSA tests lack the sensitivity and accuracy needed to reliably differentiate prostate cancer from benign prostatic hyperplasia (BPH).
  • Commercial PSA assay kits often yield incorrect values due to issues with antibody specificity, calibrator composition, and the complex nature of PSA in serum.

Purpose of the Study:

  • To address the limitations of current PSA testing.
  • To propose an improved method for prostate cancer diagnosis.
  • To enhance the differentiation between prostate cancer and BPH.

Main Methods:

  • Critically analyze factors affecting PSA assay accuracy, including antibody specificity, calibrator issues, and PSA complexation in serum.

Related Experiment Videos

  • Propose a shift in focus from measuring total PSA to specifically measuring the PSA-alpha 1-antichymotrypsin (PSA-ACT) complex.
  • Suggest simplified assay design by targeting the PSA-ACT complex.

    • Main Results:

    • The majority of PSA in serum exists as complexes with protease inhibitors, not free PSA.
    • Existing PSA assays are compromised by the dynamic nature of PSA forms and clearance rates.
    • Measuring only the PSA-ACT complex is proposed as a solution to improve assay reliability.

    Conclusions:

    • A revised PSA testing strategy focusing solely on the PSA-ACT complex could enhance diagnostic accuracy.
    • This approach may simplify assay development and improve the differentiation between prostate cancer and BPH.
    • Further development of PSA-ACT specific assays is warranted for improved prostate cancer management.